In a recent speech to Congress, Donald Trump took aim at an $8 million government investment in transgenic rodent studies, questioning the use of taxpayer funds. The studies, which were funded by the NIH, were designed to advance medical care for transgender individuals and deepen comprehension of hormone treatments. Trump highlighted a Republican-led effort to reduce superfluous expenses, a move backed by prominent figure Elon Musk. The criticism of the expenditure on these studies comes amidst a broader debate on government spending priorities and the allocation of resources in the healthcare sector.